News

Business Wire5y
Dr. Reddy's Laboratories Announces the Launch of Tobramycin Inhalation Solution, USP in the U.S. Market
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together ...
Drug Store News1y
Aurobindo Pharma’s Eugia Pharma Specialities gets FDA OK for generic Pulmicort Respules
Budesonide Inhalation Suspension, 0.5 mg/2 ml Single-Dose Ampule is indicated for maintenance treatment of asthma and as prophylactic therapy in children from 12 months old to 8 years. Aurbodino ...
The Free Press Journal1y
Aurobindo Pharma Subsidiary Eugia Pharma Receives USFDA Approval For Budesonide Inhalation Suspension
Budesonide Inhalation Suspension, 0.5 mg/2 mL Single-Dose Ampule is indicated for maintenance treatment of asthma and as prophylactic therapy in children of age 12 months to 8 years. The shares of ...